作者: Yoichi Sakata , Toshiaki Tabata , Tsukasa Ohmori , Katsuyuki Mitomo , Mamoru Hasegawa
DOI:
关键词: Coagulation Factor Gene 、 Gene 、 Factor IX 、 Vector (molecular biology) 、 Medicine 、 Immunology 、 Blood coagulation disorder 、 Hematopoietic stem cell 、 Lentivirus 、 Cancer research 、 Genetic enhancement
摘要: Disclosed is a therapeutic agent for blood coagulation disorder comprising, as an active ingredient, lentivirus vector having factor gene operably linked to promoter capable of inducing the expression in platelet-specific manner. By using encoding VIII or IX place gene, hemophilia A B can be provided. Blood treated by therapy infecting hematopoietic stem cell like with agent.